ClinicalTrials.gg
RecruitingNCT07665983BOTTLEUpdated Jul 1, 2026

The Bottle Optimization Testing Tiny Little Eaters Study

An interventional study of Feeding in Childhood Obesity, sponsored by University of Michigan. Recruiting at 1 site in United States. Open to participants aged 4 Months and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-01.

Sponsored by University of Michigan · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
440
Allocation
Not applicable
Ages
4 Months and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 558 studies in Pediatric Obesity with a site in United States — 72 open to participants now, 109 under way, 3 of them phase 3. Pediatric Obesity · United States.

Planned enrollment
79th of 475
440 · median 95
Started
2026
with 12 others
No phase
423 of 558
50 open now
Primary completion
2028-07
later than 79 of 108 live
Registered
553rd of 558
by date

Among the 558 studies in Pediatric Obesity with a site in United States, this one is the 79th largest by planned enrollment of the 475 interventional ones that give a count, is one of 13 that started in 2026, is one of 423 with no phase, reaches primary completion later than 79 of the 108 other live ones, and was the 553rd registered.

Pediatric Obesity

1,132 studies on the registry are indexed under Pediatric Obesity; 183 are open to participants now.

Browse Pediatric Obesity studies →

Open to participants now

72 of the 558 studies in Pediatric Obesity with a site in United States are open now. Recruiting first, the newest first:

66 more — sign in →

All 72 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 119 Pediatric Obesity studies recruiting now, 16 (13%) set no upper age limit and 101 (85%) stop at 75 or younger; 110 take children under 18; 67 take healthy volunteers.

This study: 4 Months and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 558 studies in Pediatric Obesity with a site in United States, or all of them as a file.
02

Study summary

The researchers will study how babies respond to bottle nipples with different flow rates over a few days, and how this may affect how much milk they drink, their feeding patterns, and their sleep.

Read the detailed description

The study will enroll 220 mother-infant dyads.

03

Conditions studied

  • Childhood Obesity

Browse trials for

Keywords

  • Infant growth
  • Responsive feeding
  • Satiation cues
  • Milk intake
04

Who can participate

Ages eligible
4 Months and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Mother-infant dyad: The biological mother is the legal guardian of the infant and has custody for ≥5 days per week (in cases of joint custody).
  2. Maternal age: Mother is ≥18 years old.
  3. Language: Mother understands spoken and written English sufficiently to provide , answer questionnaires and follow study instructions.
  4. Gestational age: Infant was born at 37.0-42.0 weeks gestation.
  5. Birthweight: Infant's birthweight was appropriate for gestational age.
  6. Bottle feeding: Infant currently receives at least one bottle feeding of ≥2 ounces at least once per week.
  7. Residence: Family lives within approximately one hours driving distance of Ann Arbor, Michigan to participate in an at- home appointment or is willing to drive to the U-M North Campus research site.
  8. Infant age: Infant is 4.0-6.0 months old at enrollment.

Exclusion criteria

Exclusion Criteria:

  1. Current maternal depression or anxiety, as assessed by screening questionnaires, or any cognitive impairment that would limit ability to follow study instructions.
  2. Infant developmental delay, genetic condition, or medical problems or diagnosis affecting current or future eating, growth, or development.
  3. History of significant sucking or feeding difficulties or breastfeeding difficulties requiring significant medical intervention or support.
  4. Current weight-for-age below the 10th percentile or significant history of poor weight gain.
  5. Infant already typically uses a slower-flow nipple (flow rate \< 5 mL/min).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
440 participants (estimated)

Study arms

  • Experimental
    Mother-infant dyad

    Each mother-infant dyad serves as its own control.

    Behavioral: Feeding

Interventions

  • BehavioralFeeding

    Following a baseline day (Day 1) in which infants are fed with their typical nipple, infants are exposed to a commercially available nipple with a 30 percent reduced flow rate for three consecutive days (Days 2-4).

06

What researchers measure

Primary outcomes

  1. Change in milk/formula intake (Δ^(S-T))

    Calculated as intake (pre-weight minus post-weight divided by infant body weight) during each slower-flow feeding minus the mean intake across the three baseline feedings

    Time frame: From baseline to the end of the slower flow feeding phase (approximately 4 days later)

Secondary outcomes

  1. Change in suck effect (Δ^(S-T))

    Measured with smart bottles and defined as the area under the sucking curve across a single feeding.

    Time frame: From baseline to the end of the slower flow feeding phase (approximately 4 days later)

  2. Change in peak tongue pressure ((Δ^(S-T))

    Measured with smart bottles and defined as the average peak of the sucking curves across a single feeding.

    Time frame: From baseline to the end of the slower flow feeding phase (approximately 4 days later)

  3. Change in sucking frequency (Δ^(S-T))

    Measured with smart bottles and defined as the average number of full suck cycles per second across a single feeding.

    Time frame: From baseline to the end of the slower flow feeding phase (approximately 4 days later)

  4. Change in sucking smoothness ((Δ^(S-T))

    Measured with smart bottles and defined as the average number of sucking pattern peaks in the speed profile of a suck across a single feeding.

    Time frame: From baseline to the end of the slower flow feeding phase (approximately 4 days later)

  5. Change in feeding Interval for each of the 12-hour segments post-introduction of the Slower-Flow bottle nipple

    Calculated as the mean Feeding Interval during the given 12-hour segment on the Slower Flow day minus the mean Feeding Interval during the matching 12-hour segment Typical nipple day.

    Time frame: From baseline to the end of the slower flow feeding phase (approximately 4 days later)

  6. Change in satiation signaling (Δ^(S-T))

    Coded set of behaviors from video recordings of feeding interactions associated with infant disengagement from the bottle or caregiver.

    Time frame: From baseline to the end of the slower flow feeding phase (approximately 4 days later)

  7. Change in dyadic mutuality between infant and caregiver (Δ^(S-T))

    Coded from video-recordings of feeding interactions, based on behaviors associated with strong communication, warmth, and synchrony of the dyad.

    Time frame: From baseline to the end of the slower flow feeding phase (approximately 4 days later)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The researchers will upload the study data to Deep Blue Data. Video-recordings and raw sucking data will not be included in the archived data on Deep Blue Data and will only be shared under appropriate data use agreements. "Deep Blue Data provides access to digital research data that were developed or used in the support of research activities at U-M. All data in the repository are available for anyone to download without restriction." https://www.lib.umich.edu/collections/deep-blue-repositories

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Data will be available by August 2029 and the researchers will leave it up a minimum of 3 years.

Access criteria: "All data in the repository are available for anyone to download without restriction." The data not in the repository, ideo-recordings and raw sucking data, University investigators pending approval of data sharing agreement.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Jul 2028, 25 months after the start.

Of 542 non-industry interventional studies with no phase under Pediatric Obesity, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 45. This study's planned 25 months is close to that.

Counting every sponsor, half of 544 studies reached it within 25 months; a quarter within 11 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 13, 2026
First posted
Jun 24, 2026
StartActual
Jun 26, 2026
Primary completionEst.
Jul 2028
CompletionEst.
Aug 2028
Last update
Jul 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07665983
Responsible party
Amanda Kinney Crandall (Research Investigator, University of Michigan) — Principal investigator
First posted
Jun 24, 2026
Start date
Jun 26, 2026
Primary completion
Jul 2028 (estimated)
Completion
Aug 2028 (estimated)
Last update
Jul 1, 2026

Study contacts

Bryanne Caldwell
Contact
bmcaldwe@umich.edu
734-647-8100
Amanda Crandall, PhD
principal investigator · University of Michigan

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion